Development of Phage Lysin LysA2 for Use in Improved Purity Assays for Live Biotherapeutic Products

MLA

Sheila M. Dreher-Lesnick, et al. “Development of Phage Lysin LysA2 for Use in Improved Purity Assays for Live Biotherapeutic Products.” Viruses, vol. 7, Dec. 2015, pp. 6675–88. EBSCOhost, https://doi.org/10.3390/v7122965.

APA

Sheila M. Dreher-Lesnick, Scott Stibitz, & Jeremy E Schreier. (2015). Development of Phage Lysin LysA2 for Use in Improved Purity Assays for Live Biotherapeutic Products. Viruses, 7, 6675–6688. https://doi.org/10.3390/v7122965

Chicago

Sheila M. Dreher-Lesnick, Scott Stibitz, and Jeremy E Schreier. 2015. “Development of Phage Lysin LysA2 for Use in Improved Purity Assays for Live Biotherapeutic Products.” Viruses 7 (December): 6675–88. doi:10.3390/v7122965.